<table width="100%" xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<col width="33%"></col>
<col width="33%"></col>
<col width="33%"></col>
<tbody>
<tr>
<td stylecode="Rrule Botrule Lrule Toprule ">
<paragraph>
<content stylecode="bold">Concomitant Drug Name or Drug Class</content>
</paragraph>
</td>
<td stylecode="Rrule Botrule Lrule Toprule ">
<paragraph>
<content stylecode="bold">Clinical Rationale</content>
</paragraph>
</td>
<td stylecode="Rrule Botrule Lrule Toprule ">
<paragraph>
<content stylecode="bold">Clinical Recommendation</content>
</paragraph>
</td>
</tr>
<tr>
<td stylecode="Rrule Lrule Botrule ">
<paragraph>Strong CYP3A4 Inhibitors (e.g., itraconazole, clarithromycin) or strong CYP2D6 inhibitors (e.g., quinidine, fluoxetine, paroxetine)</paragraph>
</td>
<td stylecode="Rrule Lrule Toprule Botrule ">
<paragraph>The concomitant use of aripiprazole with strong CYP 3A4 or CYP2D6 inhibitors increased the exposure of aripiprazole compared to the use of aripiprazole alone [<content stylecode="italics">see CLINICAL PHARMACOLOGY (<linkhtml href="#i4i_pharmacokinetics_id_fdb4fdec-7e18-40a9-99a4-15e7e2521d05">12.3</linkhtml>)</content>].</paragraph>
</td>
<td stylecode="Rrule Lrule Toprule Botrule ">
<paragraph>With concomitant use of aripiprazole with a strong CYP3A4 inhibitor or CYP2D6 inhibitor, reduce the aripiprazole dosage [<content stylecode="italics">see DOSAGE AND ADMINISTRATION (<linkhtml href="#i4i_section_id_deea4b07-7f92-422f-945a-f405bfa846bf">2.7</linkhtml>)</content>].</paragraph>
</td>
</tr>
<tr>
<td stylecode="Rrule Lrule Botrule ">
<paragraph>Strong CYP3A4 Inducers (e.g., carbamazepine, rifampin)</paragraph>
</td>
<td stylecode="Rrule Lrule Toprule Botrule ">
<paragraph>The concomitant use of aripiprazole and carbamazepine decreased the exposure of aripiprazole compared to the use of aripiprazole alone [<content stylecode="italics">see CLINICAL PHARMACOLOGY (<linkhtml href="#i4i_pharmacokinetics_id_fdb4fdec-7e18-40a9-99a4-15e7e2521d05">12.3</linkhtml>)</content>].</paragraph>
</td>
<td stylecode="Rrule Lrule Toprule Botrule ">
<paragraph>With concomitant use of aripiprazole with a strong CYP3A4 inducer, consider increasing the aripiprazole dosage [<content stylecode="italics">see DOSAGE AND ADMINISTRATION (<linkhtml href="#i4i_section_id_deea4b07-7f92-422f-945a-f405bfa846bf">2.7</linkhtml>)</content>].</paragraph>
</td>
</tr>
<tr>
<td stylecode="Rrule Lrule Botrule ">
<paragraph>Antihypertensive Drugs</paragraph>
</td>
<td stylecode="Rrule Lrule Toprule Botrule ">
<paragraph>Due to its alpha adrenergic antagonism, aripiprazole has the potential to enhance the effect of certain antihypertensive agents.</paragraph>
</td>
<td stylecode="Rrule Lrule Toprule Botrule ">
<paragraph>Monitor blood pressure and adjust dose accordingly [<content stylecode="italics">see WARNINGS AND PRECAUTIONS (<linkhtml href="#_5.7_Orthostatic_Hypotension">5.7</linkhtml>)</content>].</paragraph>
</td>
</tr>
<tr>
<td stylecode="Rrule Botrule Lrule Toprule ">
<paragraph>Benzodiazepines (e.g., lorazepam)</paragraph>
</td>
<td stylecode="Rrule Botrule Lrule Toprule ">
<paragraph>The intensity of sedation was greater with the combination of oral aripiprazole and lorazepam as compared to that observed with aripiprazole alone. The orthostatic hypotension observed was greater with the combination as compared to that observed with lorazepam alone [<content stylecode="italics">see WARNINGS AND PRECAUTIONS (<linkhtml href="#_5.7_Orthostatic_Hypotension">5.7</linkhtml>)</content>]</paragraph>
</td>
<td stylecode="Rrule Botrule Lrule Toprule ">
<paragraph>Monitor sedation and blood pressure. Adjust dose accordingly.</paragraph>
</td>
</tr>
</tbody>
</table>